Oncology/Cancer Drugs Market was accounted for $135.49 billion in 2020, and is estimated to garner $274.40 billion by 2030, growing at a CAGR of 7.5% from 2021 to 2030. Increase in incidence of cancer, rise in the global geriatric population, and surge in government expenditure on healthcare have boosted the global oncology/cancer drugs market. However, adverse effect associated with use of cancer drugs hinders the market growth. On the contrary, rise in number of pipeline drugs and high growth potential in untapped emerging economies are expected to open new opportunities for the market players in the future.
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
The global oncology/cancer drugs market report includes an in-depth analysis of the prime market players such as AbbVie Inc., Amgen, Astellas Pharma Inc., AstraZeneca PLC., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson (Janssen Global Services, LLC,), Merck & Co., Inc., Novartis AG, and Pfizer Inc.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/121
- The Covid-19 pandemic directly affected the supply of oncology drugs to cancer patients. Moreover, it became difficult to administer chemotherapy outside clinics.
- However, as the number of vaccination drives has increased, the market is expected to get back on track.
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/121
On the basis of bases, the breast cancer segment held the lion’s share in 2020, contributing to nearly one-fifth of the market. However, the lung cancer segment is estimated to portray the highest CAGR of 9.3% from 2021 to 2030.
The report offers an analysis of the global oncology/cancer drugs market across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the lion’s share in 2020, accounting for nearly half of the market. However, the market across Asia-Pacific is anticipated to showcase the highest CAGR of 9.0% during the forecast period.
Based on type, the targeted therapy segment held the largest share in 2020, accounting for more than half of the market. However, the immunotherapy segment is projected to manifest the highest CAGR of 8.7% during the forecast period.
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060